BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 30660478)

  • 1. Spinal phosphaturic mesenchymal tumors: Case report and literature review.
    Wang X; Gao J; Han S; Li Y
    J Clin Neurosci; 2019 May; 63():234-239. PubMed ID: 30660478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spinal phosphaturic mesenchymal tumors: a rare etiology causing tumor-induced osteomalacia-a review of experience at a UK tertiary referral center and literature review.
    Pannu CD; Baxter D; Anwar H
    Eur Spine J; 2024 May; 33(5):1911-1920. PubMed ID: 37964171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical treatment of recurrent spinal phosphaturic mesenchymal tumor-induced osteomalacia: A case report.
    Liu S; Zhou X; Song A; Huo Z; Wang Y; Liu Y
    Medicine (Baltimore); 2020 Jan; 99(4):e18603. PubMed ID: 31977851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphaturic Mesenchymal Tumor Involving the Head and Neck: A Report of Five Cases with FGFR1 Fluorescence In Situ Hybridization Analysis.
    Wasserman JK; Purgina B; Lai CK; Gravel D; Mahaffey A; Bell D; Chiosea SI
    Head Neck Pathol; 2016 Sep; 10(3):279-85. PubMed ID: 26759148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The phosphaturic mesenchymal tumor: why is definitive diagnosis and curative surgery often delayed?
    Ledford CK; Zelenski NA; Cardona DM; Brigman BE; Eward WC
    Clin Orthop Relat Res; 2013 Nov; 471(11):3618-25. PubMed ID: 23868423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Characteristics of Malignant Phosphaturic Mesenchymal Tumor Causing Tumor-Induced Osteomalacia.
    Abate V; Vergatti A; De Filippo G; Damiano V; Menale C; D'Elia L; Rendina D
    J Clin Endocrinol Metab; 2024 Feb; 109(3):e1006-e1011. PubMed ID: 38006315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-induced Osteomalacia due to a Phosphaturic Mesenchymal Tumor in the Cervical Spine: A Case Report and Literature Review.
    Agarwal N; Kale SS; Kumari K
    Neurol India; 2019; 67(5):1334-1340. PubMed ID: 31744971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogenic osteomalacia due to phosphaturic mesenchymal tumour in the upper thoracic spine.
    Garg B; Mehta N; Goyal A; Khadgawat R
    BMJ Case Rep; 2020 Dec; 13(12):. PubMed ID: 33328210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic osteomalacia caused by a phosphaturic mesenchymal tumor of the thoracic spine.
    Pirola E; Vergani F; Casiraghi P; Leone EB; Guerra P; Sganzerla EP
    J Neurosurg Spine; 2009 Apr; 10(4):329-33. PubMed ID: 19441990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment and Diagnose of Spinal Phosphaturic Mesenchymal Tumor: A Case Report and a Systematic Literature Review.
    Chen D; Zhang L; Zhang J; Yin M; Gao X; Huang Q; Li L; Yang X
    World Neurosurg; 2024 Apr; 184():65-73. PubMed ID: 38218444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment and outcomes of tumor-induced osteomalacia associated with phosphaturic mesenchymal tumors: retrospective review of 12 patients.
    Zuo QY; Wang H; Li W; Niu XH; Huang YH; Chen J; You YH; Liu BY; Cui AM; Deng W
    BMC Musculoskelet Disord; 2017 Sep; 18(1):403. PubMed ID: 28934935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-induced osteomalacia: An overview.
    Jadhav SS; Shah R; Patil V
    Best Pract Res Clin Endocrinol Metab; 2024 Mar; 38(2):101834. PubMed ID: 37935612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Phosphaturic Mesenchymal Tumor Presenting as Reversible Metabolic Myopathy.
    Abdulla M
    Saudi J Kidney Dis Transpl; 2023 Nov; 34(6):666-670. PubMed ID: 38725216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent phosphaturic mesenchymal tumor causing tumor-induced osteomalacia treated with image-guided ablation.
    Horng JC; Van Eperen E; Tutton S; Singh R; Shaker JL; Wooldridge AN
    Osteoporos Int; 2021 Sep; 32(9):1895-1898. PubMed ID: 33655402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thoracic phosphaturic mesenchymal tumors causing oncogenic osteomalacia.
    Puthenveetil PJ; Hattab EM; Peacock M; Horn EM
    J Clin Neurosci; 2013 Aug; 20(8):1057-61. PubMed ID: 23618679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphaturic mesenchymal tumors show positive staining for somatostatin receptor 2A (SSTR2A).
    Houang M; Clarkson A; Sioson L; Elston MS; Clifton-Bligh RJ; Dray M; Ranchere-Vince D; Decouvelaere AV; de la Fouchardiere A; Gill AJ
    Hum Pathol; 2013 Dec; 44(12):2711-8. PubMed ID: 24060005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracranial phosphaturic mesenchymal tumors. A case report and review of literature.
    Kojima D; Ohba S; Abe M; Suzuki A; Horibe S; Tateya I; Hasegawa M; Hirose Y
    Neuropathology; 2022 Oct; 42(5):453-458. PubMed ID: 35880350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphaturic mesenchymal tumors: A review and update.
    Folpe AL
    Semin Diagn Pathol; 2019 Jul; 36(4):260-268. PubMed ID: 31301876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant phosphaturic mesenchymal tumor with pulmonary metastasis: A case report.
    Qiu S; Cao LL; Qiu Y; Yan P; Li ZX; Du J; Sun LM; Zhang QF
    Medicine (Baltimore); 2017 Apr; 96(17):e6750. PubMed ID: 28445300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphaturic mesenchymal tumor of the nasal cavity and paranasal sinuses: A clinical curiosity presenting a diagnostic challenge.
    Kane SV; Kakkar A; Oza N; Sridhar E; Pai PS
    Auris Nasus Larynx; 2018 Apr; 45(2):377-383. PubMed ID: 28579442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.